Bit Bio is a synthetic biology company focused on coding cells for life. They are advancing human health by providing every biologist with access to consistent and scalable batches of human cells for research, drug discovery, and cell therapy. Their proprietary opti-ox™ precision cell programming and manufacturing technology enables the rapid and consistent generation of any human cell type, aiming to solve the challenges of reproducibility and scalability in cell-based research and therapeutics.
Serves as the primary center for research and development (R&D), corporate operations, strategic planning, and advanced manufacturing of their cell products.
State-of-the-art laboratory facilities, access to shared campus resources, and a highly collaborative environment within the Babraham Research Campus, known for its cutting-edge life sciences research.
A dynamic, innovative, and science-driven environment characterized by a passion for discovery, collaboration, and a mission-driven approach to solving complex biological challenges. Emphasis on learning and development.
Its location in Cambridge provides access to world-class academic institutions, a rich talent pool, potential collaborators, and a supportive ecosystem for biotech growth and investment.
While headquartered in the UK, Bit Bio supports a global customer base across academia, pharmaceutical, and biotechnology sectors. Their products are distributed internationally, and they engage in collaborations worldwide. Key functions supported globally include sales, customer support, and scientific collaborations, with a growing commercial footprint in North America and considerations for Asia-Pacific markets.
Building 920, Babraham Research Campus
Cambridge
Cambridgeshire
United Kingdom
Address: Commercial Operations Hub (specific address not publicly listed for general inquiries, often distributed or co-working for commercial teams)
To establish and grow Bit Bio's presence in the key US market, engage with customers and partners in biotech and pharma, and drive adoption of their cell products and technologies.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, bit.bio' leadership includes:
bit.bio has been backed by several prominent investors over the years, including:
Bit Bio has made strategic additions to its executive team over the past year to bolster its commercial and operational capabilities as it scales. Notably, Paul Morrill joined as CBO.
Discover the tools bit.bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Bit Bio likely uses standard corporate email formats. The most common formats for tech and biotech companies are 'first.last@domain.com' or 'firstinitiallast@domain.com'. Given their domain 'bit.bio', these are strong possibilities.
first.last@bit.bio or flast@bit.bio
Format
jane.doe@bit.bio
Example
90%
Success rate
Bit Bio Press Release • 2024-02-27
Bit Bio announced it has achieved ISO 9001:2015 certification for its Quality Management Systems (QMS), underscoring its commitment to delivering high-quality, consistent human cells for research and drug discovery....more
Bit Bio Press Release / Fierce Biotech • 2023-11-09
Bit Bio and Charles River Laboratories International, Inc. announced a strategic partnership to combine Bit Bio’s opti-ox™ precision cell programming technology with Charles River’s contract development and manufacturing (CDMO) capabilities for iPSC-derived cells....more
Cell and Gene Therapy Catapult • 2023-10-17
Bit Bio was announced as one of the collaborators joining the Cell and Gene Therapy Catapult’s (CGT Catapult) new iPSC-Derived Cell Therapy Manufacturing Innovation Centre (MIC) to advance the industrialisation of iPSC-derived cell therapies....more
Bit Bio Press Release / Business Wire • 2023-05-23
Bit Bio launched ioSkeletal Myocytes™, human iPSC-derived skeletal muscle cells, powered by its opti-ox technology. These cells provide a consistent and scalable supply for research into muscle biology and diseases like muscular dystrophy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including bit.bio, are just a search away.